医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.

广告
第一作者: Michael,Menzel
第一单位: Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.;Center for Personalized Medicine (ZPM), Heidelberg, Germany.
作者单位: Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.;Center for Personalized Medicine (ZPM), Heidelberg, Germany. [1] Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.;Center for Personalized Medicine (ZPM), Tübingen, Germany.;Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, Germany. [2] Institute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.;Center for Personalized Medicine (ZPM), Freiburg, Germany. [3] Center for Personalized Medicine (ZPM), Freiburg, Germany.;Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [4] Center for Personalized Medicine (ZPM), Heidelberg, Germany.;Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.;German Cancer Consortium (DKTK), Heidelberg, Germany. [5] Institute of Pathology, University Hospital Ulm, Ulm, Germany.;Center for Personalized Medicine (ZPM), Ulm, Germany. [6] Center for Personalized Medicine (ZPM), Freiburg, Germany.;Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;Comprehensive Cancer Center Freiburg (CCCF), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Cancer Consortium (DKTK) Partner Site Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany. [7] Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.;Center for Personalized Medicine (ZPM), Tübingen, Germany. [8] Institute of Pathology, University Hospital Ulm, Ulm, Germany.;Center for Personalized Medicine (ZPM), Ulm, Germany.;Institute of Medical Systems Biology, Ulm University, Ulm, Germany. [9] Institute of Pathology, University Hospital Ulm, Ulm, Germany. [10] Center for Personalized Medicine (ZPM), Freiburg, Germany.;Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Cancer Consortium (DKTK) Partner Site Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany. [11] Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.;Center for Personalized Medicine (ZPM), Heidelberg, Germany.;Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore. [12] Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.;Center for Personalized Medicine (ZPM), Heidelberg, Germany.;Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. [13] Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany. [14] Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79085, Freiburg, Germany.;Medical Department for Hematology and Oncology, Klinikum Rechts der Isar, Technische Universität München, 80333, Munich, Germany.;German Cancer Consortium (DKTK) Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. [15] Institute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, Germany.;Center for Personalized Medicine (ZPM), Freiburg, Germany.;German Cancer Consortium (DKTK) Partner Site Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany. [16] Center for Personalized Medicine (ZPM), Ulm, Germany.;Department of Internal Medicine I, University of Ulm, Ulm, Germany. [17] Center for Personalized Medicine (ZPM), Tübingen, Germany.;Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. [18] Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.;Center for Personalized Medicine (ZPM), Heidelberg, Germany.;German Cancer Consortium (DKTK), Heidelberg, Germany. [19] Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. jan.budczies@med.uni-heidelberg.de.;Center for Personalized Medicine (ZPM), Heidelberg, Germany. jan.budczies@med.uni-heidelberg.de.;German Cancer Consortium (DKTK), Heidelberg, Germany. jan.budczies@med.uni-heidelberg.de. [20] Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. albrecht.stenzinger@med.uni-heidelberg.de.;Center for Personalized Medicine (ZPM), Heidelberg, Germany. albrecht.stenzinger@med.uni-heidelberg.de.;German Cancer Consortium (DKTK), Heidelberg, Germany. albrecht.stenzinger@med.uni-heidelberg.de. [21]
DOI 10.1038/s41698-023-00457-x
PMID 37864096
发布时间 2023-11-18
提交
  • 浏览0
NPJ precision oncology

NPJ precision oncology

2023年7卷1期

106页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷